Alpha 2.0
Login Register
» Articles » PMID: 10470419

Microsatellite Instability (MSI) in Non-colonic, Non-HNPCC Tumors: 'instable' Evidence?

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 1999 Sep 2
PMID 10470419
Citations 5
Authors
N Papadopoulos
Affiliations
Soon will be listed here.
Citing Articles

Therapeutic potential of Xihuang Pill in colorectal cancer: Metabolomic and microbiome-driven approaches.

Zhang C, Sui C, Ma X, Ma C, Sun X, Zhai C Front Pharmacol. 2024; 15:1402448.

PMID: 39687297 PMC: 11646767. DOI: 10.3389/fphar.2024.1402448.

Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the Colorectal Cancer With Microsatellite Stability.

Yu G, Wang W, He X, Xu J, Xu R, Wan T Front Oncol. 2022; 12:895103.

PMID: 35774131 PMC: 9239344. DOI: 10.3389/fonc.2022.895103.

Sulindac Modulates the Response of Proficient MMR Colorectal Cancer to Anti-PD-L1 Immunotherapy.

Yi B, Cheng H, Wyczechowska D, Yu Q, Li L, Ochoa A Mol Cancer Ther. 2021; 20(7):1295-1304.

PMID: 33879557 PMC: 8295201. DOI: 10.1158/1535-7163.MCT-20-0934.

Gene mapping and molecular analysis of hereditarynon-polyposis colorectal cancer (Lynch Syndrome)using systems biological approaches.

Rasool M, Karim S, Naseer M, Pushparaj P, Abuzenadah A, Al-Qahtani M Bioinformation. 2019; 15(4):269-276.

PMID: 31285644 PMC: 6599435. DOI: 10.6026/97320630015269.

Low-dose decitabine enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by re-modulating the tumor microenvironment.

Yu G, Wu Y, Wang W, Xu J, Lv X, Cao X Cell Mol Immunol. 2018; 16(4):401-409.

PMID: 29622799 PMC: 6461874. DOI: 10.1038/s41423-018-0026-y.